# Study of a pd VWF/FVIII Concentrate, Biostate®, in Subjects With Von Willebrand Disease

> **NCT00941616** · PHASE2,PHASE3 · COMPLETED · sponsor: **CSL Behring** · enrollment: 22 (actual)

## Conditions studied

- Von Willebrand Disease

## Interventions

- **BIOLOGICAL:** Biostate®
- **BIOLOGICAL:** Biostate®

## Key facts

- **NCT ID:** NCT00941616
- **Lead sponsor:** CSL Behring
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2017-10-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00941616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00941616, "Study of a pd VWF/FVIII Concentrate, Biostate®, in Subjects With Von Willebrand Disease". Retrieved via AI Analytics 2026-08-21 from https://api.ai-analytics.org/clinical/NCT00941616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*